Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7444575 | 0.95 | ICMT (0.35) | ICMTNQO1 | |
| SCHEMBL7447997 | 0.91 | ICMT (0.33) | ICMTNQO1 | |
| SCHEMBL7435600 | 0.87 | NQO1 (0.31) | ICMTNQO1 | |
| SCHEMBL7446268 | 0.87 | HPGD (0.36) | — | |
| SCHEMBL7483350 | 0.86 | NQO1 (0.34) | ICMTNQO1 | |
| SCHEMBL7450257 | 0.85 | ALDH1A1 (0.36) | — | |
| SCHEMBL7443868 | 0.85 | ALDH1A1 (0.31) | — | |
| SCHEMBL7443227 | 0.84 | LMNA (0.33) | ICMTNQO1 | |
| SCHEMBL7445304 | 0.82 | NQO1 (0.31) | ICMTNQO1 | |
| SCHEMBL7445490 | 0.82 | ERCC5 (0.31) | NQO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0668860-B1 | PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES | UPJOHN CO (US) | 2002-09-11 | — | — | EP | claimed |
| WO-1994011361-A1 | PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES | THE UPJOHN COMPANY (US) | 1994-05-26 | — | — | WO | claimed |
| EP-1203770-A1 | Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hyperplasia and other diseases | PHARMACIA & UPJOHN COMPANY (US) | 2002-05-08 | — | — | EP | disclosed |
| WO-1994011361-A1 | PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES | THE UPJOHN COMPANY (US) | 1994-05-26 | — | — | WO | disclosed |